Ocugen Inc (NASDAQ:OCGN) has a beta value of 3.70 and has seen 1.35 million shares traded in the recent trading session. The company, currently valued at $210.87M, closed the recent trade at $0.72 per share which meant it lost -$0.08 on the day or -9.68% during that session. The OCGN stock price is -188.89% off its 52-week high price of $2.08 and 29.17% above the 52-week low of $0.51. If we look at the company’s 10-day average daily trading volume, we find that it stood at 4.31 million shares traded. The 3-month trading volume is 4.13 million shares.
The consensus among analysts is that Ocugen Inc (OCGN) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 5 have rated it as a Hold, with 5 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.06.
Ocugen Inc (NASDAQ:OCGN) trade information
Sporting -9.68% in the red today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the OCGN stock price touched $0.72 or saw a rise of 10.0%. Year-to-date, Ocugen Inc shares have moved -10.30%, while the 5-day performance has seen it change 13.29%. Over the past 30 days, the shares of Ocugen Inc (NASDAQ:OCGN) have changed 10.80%. Short interest in the company has seen 67.51 million shares shorted with days to cover at 17.7.
Wall Street analysts have a consensus price target for the stock at $5, which means that the shares’ value could jump 85.6% from the levels at last check today.. The projected low price target is $3.5 while the price target rests at a high of $6.0. In that case, then, we find that the latest price level in today’s session is -733.33% off the targeted high while a plunge would see the stock gain -386.11% from the levels at last check today..
Ocugen Inc (OCGN) estimates and forecasts
The company’s shares have lost -26.72% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -100.00%.
Year-ago sales stood 1.01M and 1.14M respectively for this quarter and the next, and analysts expect sales will shrink by -100.00% for the current quarter and -100.00% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 32.82% over the past 5 years.
OCGN Dividends
Ocugen Inc is expected to release its next earnings report on 2025-Mar-04 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Ocugen Inc (NASDAQ:OCGN)’s Major holders
Insiders own 1.27% of the company shares, while shares held by institutions stand at 24.84% with a share float percentage of 25.16%. Investors are also buoyed by the number of investors in a company, with Ocugen Inc having a total of 149.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 17.92 million shares worth more than $27.78 million. As of 2024-06-30, BLACKROCK INC. held 6.9632% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 15.52 million shares as of 2024-06-30. The firm’s total holdings are worth over $24.06 million and represent 6.0339% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . As of Dec 31, 2024 , the former fund manager holds about 3.11% shares in the company for having 9.07 shares of worth $6.58 million while later fund manager owns 7.38 shares of worth $5.35 million as of Feb 28, 2025 , which makes it owner of about 2.53% of company’s outstanding stock.
